# OnCo record emerald (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/emerald/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "emerald", "NCT03778931" ;
  schema:name "EMERALD"@en ;
  schema:description "The first oral oestrogen-receptor degrader to beat standard hormone therapy, with the benefit concentrated in tumours carrying ESR1 mutations."@en ;
  schema:url <https://onco.cc/trials/emerald/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03778931> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2019-05-10" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/elacestrant/> ;
  onco:terms <https://onco.cc/terms/esr1-mutation/> ;
  onco:people <https://onco.cc/people/francois-clement-bidard/>, <https://onco.cc/people/aditya-bardia/> .